Sagimet Biosciences (SGMT) Current Assets: 2023-2024
Historic Current Assets for Sagimet Biosciences (SGMT) over the last 2 years, with Sep 2024 value amounting to $157.2 million.
- Sagimet Biosciences' Current Assets rose 52.88% to $157.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $157.2 million, marking a year-over-year increase of 52.88%. This contributed to the annual value of $96.6 million for FY2023, which is N/A change from last year.
- According to the latest figures from Q3 2024, Sagimet Biosciences' Current Assets is $157.2 million, which was down 5.73% from $166.8 million recorded in Q2 2024.
- In the past 5 years, Sagimet Biosciences' Current Assets registered a high of $194.5 million during Q1 2024, and its lowest value of $21.4 million during Q2 2023.
- For the 2-year period, Sagimet Biosciences' Current Assets averaged around $123.2 million, with its median value being $130.0 million (2023).
- Data for Sagimet Biosciences' Current Assets shows a peak YoY soared of 680.89% (in 2024) over the last 5 years.
- Quarterly analysis of 2 years shows Sagimet Biosciences' Current Assets stood at $96.6 million in 2023, then soared by 52.88% to $157.2 million in 2024.
- Its Current Assets stands at $157.2 million for Q3 2024, versus $166.8 million for Q2 2024 and $194.5 million for Q1 2024.